CoChat

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω‐Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

Open access
Hardwick, James P., Osei-Hyiaman, Douglas, Wiland, Homer, Abdelmegeed, Mohamed A., Song, Byoung-Joon · 2009 · PPAR Research
Cited by 148

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Fatty liver disease is a common lipid metabolism disorder influenced by the combination of individual genetic makeup, drug exposure, and life‐style choices that are frequently associated with metabolic syndrome, which encompasses obesity, dyslipidemia, hypertension, hypertriglyceridemia, and insulin resistant diabetes. Common to obesity related dyslipidemia is the excessive storage of hepatic fatty acids (steatosis), due to a decrease in mitochondria β‐oxidation with an increase in both peroxisomal β‐oxidation, and microsomal ω‐oxidation of fatty acids through peroxisome proliferator activated receptors (PPARs). How steatosis increases PPAR α activated gene expression of fatty acid transport proteins, peroxisomal and mitochondrial fatty acid β‐oxidation and ω‐oxidation of fatty acids genes regardless of whether dietary fatty acids are polyunsaturated (PUFA), monounsaturated (MUFA), or saturated (SFA) may be determined by the interplay of PPARs and HNF4 α with the fatty acid transport proteins L‐FABP and ACBP. In hepatic steatosis and steatohepatitis, the ω‐oxidation cytochrome P450 CYP4A gene expression is increased even with reduced hepatic levels of PPAR α. Although numerous studies have suggested the role ethanol‐inducible CYP2E1 in contributing to increased oxidative stress,Cyp2e1‐null mice still develop steatohepatitis with a dramatic increase in CYP4A gene expression. This strongly implies that CYP4A fatty acid ω‐hydroxylase P450s may play an important role in the development of steatohepatitis. In this review and tutorial, we briefly describe how fatty acids are partitioned by fatty acid transport proteins to either anabolic or catabolic pathways regulated by PPARs, and we explore how medium‐chain fatty acid (MCFA)CYP4A and long‐chain fatty acid (LCFA)CYP4Fω‐hydroxylase genes are regulated in fatty liver. We finally propose a hypothesis that increased CYP4A expression with a decrease in CYP4F genes may promote the progression of steatosis to steatohepatitis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2009/952734

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 148

Metadata

Authors
Hardwick, J. P., Osei-Hyiaman, D., Wiland, H., Abdelmegeed, M. A., & Song, B.-J.
Venue
PPAR Research
Publisher
Wiley
Published
2009-01
Volume
2009
Issue
1
Pages
952734-952734
ISSN
  • 1687-4757 (ISSN-L)
  • 1687-4765
OpenAlex
W1964775061
Cited by
148
References
27
FWCI
1.80
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω‐Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease. https://app.cochat.ai/papers/10.1155/2009/952734
The paper
Hardwick, J. P., Osei-Hyiaman, D., Wiland, H., Abdelmegeed, M. A., & Song, B.-J. (2009). PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω‐Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease. PPAR Research. https://doi.org/10.1155/2009/952734

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.